YouCai Yi
Xiao-Yu Chen
Jin-Shui Zhu
*
Jing Zhang
*This article is a correction to:
Dihydroartemisinin Suppresses the Tumorigenesis and Cycle Progression of Colorectal Cancer by Targeting CDK1/CCNB1/PLK1 Signaling
CORRECTION article
Front. Oncol.
Sec. Pharmacology of Anti-Cancer Drugs
Volume 14 - 2024 |
doi: 10.3389/fonc.2024.1387599
Corrigendum: Dihydroartemisinin Suppresses the Tumorigenesis and Cycle Progression of Colorectal Cancer by Targeting CDK1/CCNB1/PLK1 Signaling
Provisionally accepted- Shanghai Sixth People's Hospital, Shanghai Jiao Tong University, Shanghai, Shanghai Municipality, China
The final, formatted version of the article will be published soon.
Keywords: Dihydroartemisinin, Cell Cycle, Cdk1, colorectal cancer, Growth, CCNB1
Received: 18 Feb 2024; Accepted: 20 Feb 2024.
Copyright: © 2024 Yi, Liang, Chen, Fan, Chen, Zhu and Zhang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Jin-Shui Zhu, Shanghai Sixth People's Hospital, Shanghai Jiao Tong University, Shanghai, 200233, Shanghai Municipality, China
Jing Zhang, Shanghai Sixth People's Hospital, Shanghai Jiao Tong University, Shanghai, 200233, Shanghai Municipality, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.